Astera Labs (NASDAQ:ALAB) Trading Up 1.8% – Here’s What Happened

Shares of Astera Labs, Inc. (NASDAQ:ALAB) were up 1.8% during mid-day trading on Friday . The company traded as high as $239.77 and last traded at $232.68. Approximately 5,923,016 shares traded hands during trading, an increase of 10% from the average daily volume of 5,394,691 shares. The stock had previously closed at $228.64.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Northland Securities sharply raised its earnings outlook for Astera Labs (ALAB) across multiple periods, including FY2026, FY2027, and several quarterly estimates, signaling stronger expected profitability ahead.
• Positive Sentiment: Analyst sentiment is also improving elsewhere, with another report lifting ALAB’s price target to $246.06, reinforcing the view that Wall Street sees more upside in the stock. Astera Labs price target increased by 20.85% to 246.06
• Positive Sentiment: Zacks highlighted strong UALink 2.0 momentum and Scorpio switch expansion, saying these products are helping drive Astera Labs’ AI infrastructure growth and could support additional upside as deployments build into 2027. ALAB Benefits From Strong UALink Growth: More Upside Ahead?

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on ALAB shares. Jefferies Financial Group restated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Morgan Stanley upped their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Needham & Company LLC upped their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. UBS Group assumed coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Finally, Stifel Nicolaus upped their price objective on shares of Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Fifteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $229.65.

Astera Labs Stock Performance

The stock has a market cap of $39.88 billion, a price-to-earnings ratio of 157.22, a price-to-earnings-growth ratio of 3.08 and a beta of 3.35. The company’s 50 day simple moving average is $155.40 and its two-hundred day simple moving average is $156.41.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the business earned $0.33 EPS. The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, CFO Michael Truett Tate sold 12,001 shares of the stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the transaction, the chief financial officer owned 192,083 shares in the company, valued at $23,781,796.23. This represents a 5.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,497,338 shares of company stock worth $236,827,957. Company insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Nordea Investment Management AB bought a new stake in shares of Astera Labs during the 4th quarter worth $2,028,000. Geneva Partners LLC bought a new stake in shares of Astera Labs during the 3rd quarter worth $1,876,000. Numerai GP LLC boosted its holdings in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after buying an additional 7,992 shares during the period. Handelsbanken Fonder AB boosted its holdings in shares of Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after buying an additional 93,800 shares during the period. Finally, Paragon Advisors LLC bought a new stake in shares of Astera Labs during the 3rd quarter worth $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.